PACAP prevents toxicity induced by cisplatin in rat and primate neurons but not in proliferating ovary cells: Involvement of the mitochondrial apoptotic pathway

Neurobiology of Disease

Volumn 32, Issue 1, 2008, Pages 66-80

  Aubert, Nicolas ^a,b   Vaudry, David ^a   Falluel Morel, Anthony ^a   Desfeux, Arnaud ^a   Fisch, Cécile ^b   Ancian, Philippe ^b   de Jouffrey, Stéphane ^b   Le Bigot, Jean François ^b   Couvineau, Alain ^c   Laburthe, Marc ^c   Fournier, Alain ^d   Laudenbach, Vincent ^a   Vaudry, Hubert ^a   Gonzalez, Bruno J ^a  

^a INSERM   (France)

^b CIT   (France)

^c CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^d INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Apoptosis; Bax; Cerebellum; Chemotherapy; Neuroprotection

Indexed keywords

CASPASE 3; CASPASE 9; CISPLATIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; SPHINGOMYELIN PHOSPHODIESTERASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; MITOCHONDRION; NERVE CELL; NEUROTOXICITY; NONHUMAN; OVARY CELL; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CALLITHRIX; CELL PROLIFERATION; CELLS, CULTURED; CHO CELLS; CISPLATIN; CRICETINAE; CRICETULUS; FEMALE; MACACA FASCICULARIS; MALE; MITOCHONDRIAL PROTEINS; NEURONS; ORGAN CULTURE TECHNIQUES; OVARY; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 51549115612     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.06.014     Document Type: Article

References (70)

1. Abraham M.C., and Shaham S. Death without caspases, caspases without death. Trends Cell Biol. 14 (2004) 184-193
2. Allais A., Burel D., Isaac E.R., Gray S.L., Basille M., Ravni A., Sherwood N.M., Vaudry H., and Gonzalez B.J. Altered cerebellar development in mice lacking pituitary adenylate cyclase-activating polypeptide. Eur. J. Neurosci. 25 (2007) 2604-2618
3. Allen J.W., Eldadah B.A., Huang X., Knoblach S.M., and Faden A.I. Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis. J. Neurosci. Res. 65 (2001) 45-53
4. Aubert N., Falluel-Morel A., Vaudry D., Xifro X., Rodriguez-Alvarez J., Fisch C., de Jouffrey S., Lebigot J.F., Fournier A., Vaudry H., and Gonzalez B.J. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression. J. Neurochem. 99 (2006) 1237-1250
5. Basille M., Vaudry D., Coulouarn Y., Jegou S., Lihrmann I., Fournier A., Vaudry H., and Gonzalez B. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development. J. Comp. Neurol. 425 (2000) 495-509
6. Basille M., Cartier D., Vaudry D., Lihrmann I., Fournier A., Freger P., Gallo-Payet N., Vaudry H., and Gonzalez B.J. Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development. J. Comp. Neurol. 496 (2006) 468-478
7. Biro K., Noszek L., Prekopp P., Nagyivanyi K., Geczi L., Gaudi I., and Bodrogi I. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission. Oncology 70 (2006) 177-184
8. Brewster J.L., Linseman D.A., Bouchard R.J., Loucks F.A., Precht T.A., Esch E.A., and Heidenreich K.A. Endoplasmic reticulum stress and trophic factor withdrawal activate distinct signaling cascades that induce glycogen synthase kinase-3 beta and a caspase-9-dependent apoptosis in cerebellar granule neurons. Mol. Cell. Neurosci. 32 (2006) 242-253
9. Chartrel N., Tonon M.C., Vaudry H., and Conlon J.M. Primary structure of frog pituitary adenylate cyclase-activating polypeptide (PACAP) and effects of ovine PACAP on frog pituitary. Endocrinology 129 (1991) 3367-3371
10. Cummings B.S., and Schnellmann R.G. Cisplatin-induced renal cell apoptosis: caspase-3-dependent and -independent pathways. J. Pharmacol. Exp. Ther. 302 (2002) 8-17
11. Dickey D.T., Wu Y.J., Muldoon L.L., and Neuwelt E.A. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels. J. Pharmacol. Exp. Ther. 314 (2005) 1052-1058
12. Dimanche-Boitrel M.T., Meurette O., Rebillard A., and Lacour S. Role of early plasma membrane events in chemotherapy-induced cell death. Drug Resist. Updat. 8 (2005) 5-14
13. Eastman A. Analysis and quantitation of the DNA damage produced in cells by the cisplatin analog cis-[3H]dichloro(ethylenediamine)platinum. Anal. Biochem. 197 (1991) 311-315
14. Evans D.L., Tilby M., and Dive C. Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation. Cancer Res. 54 (1994) 1596-1603
15. Fadeel B., and Orrenius S. Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J. Intern. Med. 258 (2005) 479-517
16. Falluel-Morel A., Aubert N., Vaudry D., Basille M., Fontaine M., Fournier A., Vaudry H., and Gonzalez B.J. Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. J. Neurochem. 91 (2004) 1231-1243
17. Fisher D.E. Apoptosis in cancer therapy: crossing the threshold. Cell 78 (1994) 539-542
18. Gabaizadeh R., Staecker H., Liu W., Kopke R., Malgrange B., Lefebvre P.P., and Van de Water T.R. Protection of both auditory hair cells and auditory neurons from cisplatin induced damage. Acta Otolaryngol. 117 (1997) 232-238
19. Gonzalez B., Leroux P., Lamacz M., Bodenant C., Balazs R., and Vaudry H. Somatostatin receptors are expressed by immature cerebellar granule cells: evidence for a direct inhibitory effect of somatostatin on neuroblast activity. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 9627-9631
20. Gonzalez B.J., Basille M., Vaudry D., Fournier A., and Vaudry H. Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts. Neuroscience 78 (1997) 419-430
21. Gonzalez V.M., Fuertes M.A., Alonso C., and Perez J.M. Is cisplatin-induced cell death always produced by apoptosis? Mol. Pharmacol. 59 (2001) 657-663
22. Gressens P., Arquié C., Hill J.M., Marret S., Sahir N., Robberecht P., and Evrard P. VIP and PACAP 38 modulate ibotenate-induced neuronal heterotopias in the newborn hamster neocortex. J. Neuropathol. Exp. Neurol. 59 (2000) 1051-1062
23. Grumolato L., Elkahloun A.G., Ghzili H., Alexandre D., Coulouarn C., Yon L., Salier J.P., Eiden L.E., Fournier A., Vaudry H., and Anouar Y. Microarray and suppression subtractive hybridization analyses of gene expression in pheochromocytoma cells reveal pleiotropic effects of pituitary adenylate cyclase-activating polypeptide on cell proliferation, survival, and adhesion. Endocrinology 144 (2003) 2368-2379
24. Harada J., and Sugimoto M. An inhibitor of p38 and JNK MAP kinases prevents activation of caspase and apoptosis of cultured cerebellar granule neurons. Jpn. J. Pharmacol. 79 (1999) 369-378
25. Howley, B., Fearnhead, H.O., in press. Caspases as therapeutic targets. J. Cell. Mol. Med.
26. Hu Z., Lelievre V., Rodriguez W.I., Tam J., Cheng J.W., Cohen-Cory S., and Waschek J.A. Embryonic expression of pituitary adenylyl cyclase-activating polypeptide and its selective type I receptor gene in the frog Xenopus laevis neural tube. J. Comp. Neurol. 441 (2001) 266-275
27. Jordan P., and Carmo-Fonseca M. Molecular mechanisms involved in cisplatin cytotoxicity. Cell. Mol. Life Sci. 57 (2000) 1229-1235
28. Kuida K., Zheng T.S., Na S., Kuan C., Yang D., Karasuyama H., Rakic P., and Flavell R.A. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384 (1996) 368-372
29. Kuida K., Lippke J.A., Ku G., Harding M.W., Livingston D.J., Su M.S., and Flavell R.A. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267 (1995) 2000-2003
30. Lei K., and Davis R.J. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2432-2437
31. Mandic A., Hansson J., Linder S., and Shoshan M.C. Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J. Biol. Chem. 278 (2003) 9100-9106
32. Mabuchi S., Ohmichi M., Nishio Y., Hayasaka T., Kimura A., Ohta T., Saito M., Kawagoe J., Takahashi K., Yada-Hashimoto N., Sakata M., Motoyama T., Kurachi H., Tasaka K., and Murata Y. Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J. Biol. Chem. 279 (2004) 23477-23485
33. Malgrange B., Delrée P., Rigo J.M., Baron H., and Moonen G. Image analysis of neuritic regeneration by adult rat dorsal root ganglion neurons in culture: quantification of the neurotoxicity of anticancer agents and of its prevention by nerve growth factor or basic fibroblast growth factor but not brain-derived neurotrophic factor or neurotrophin-3. J. Neurosci. Methods 53 (1994) 111-122
34. Marchesini N., Luberto C., and Hannun Y.A. Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism. J. Biol. Chem. 278 (2003) 13775-13783
35. Mattson M.P., and Kroemer G. Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. Trends Mol. Med. 9 (2003) 196-205
36. Matsui T., Ramasamy K., Ingelsson M., Fukumoto H., Conrad C., Frosch M.P., Irizarry M.C., Yuan J., and Hyman B.T. Coordinated expression of caspase 8, 3 and 7 mRNA in temporal cortex of Alzheimer disease: relationship to formic acid extractable abeta42 levels. J. Neuropathol. Exp. Neurol. 65 (2006) 508-515
37. Mellor H.R., Ferguson D.J., and Callaghan R. A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs. Br. J. Cancer 93 (2005) 302-309
38. Miranda M.B., Dyer K.F., Grandis J.R., and Johnson D.E. Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation: a requirement for Bcl-X(L)and XIAP in the prolonged survival of monocytic cells. Leukemia 17 (2003) 390-400
39. Miyata A., Arimura A., Dahl R.R., Minamino N., Uehara A., Jiang L., Culler M.D., and Coy D.H. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164 (1989) 567-574
40. Modrak D.E., Rodriguez M.D., Goldenberg D.M., Lew W., and Blumenthal R.D. Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumor xenografts. Int. J. Oncol. 20 (2002) 379-384
41. Nakamura T., Nakajima Y., Enomoto T., Hori S., Hidaka T., Murata Y., and Saito S. Cisplatin enhances the p53-independent apoptosis induced by a topoisomerase I inhibitor (CPT-11) in the lens epithelial tumors in transgenic mice. Oncol. Rep. 12 (2004) 253-258
42. Nicot A., Lelievre V., Tam J., Waschek J.A., and DiCicco-Bloom E. Pituitary adenylate cyclase-activating polypeptide and sonic hedgehog interact to control cerebellar granule precursor cell proliferation. J. Neurosci. 22 (2002) 9244-9254
43. Noda S., Yoshimura S., Sawada M., Naganawa T., Iwama T., Nakashima S., and Sakai N. Role of ceramide during cisplatin-induced apoptosis in C6 glioma cells. J. Neurooncol. 52 (2001) 11-21
44. Ohta T., Ohmichi M., Hayasaka T., Mabuchi S., Saitoh M., Kawagoe J., Takahashi K., Igarashi H., Du B., Doshida M., Mirei I.G., Motoyama T., Tasaka K., and Kurachi H. Inhibition of phosphatidylinositol 3-kinase increases efficacy of cisplatin in in vivo ovarian cancer models. Endocrinology 147 (2006) 1761-1769
45. Qin L.F., and Ng I.O. Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells. Cancer Lett. 175 (2002) 27-38
46. Quasthoff S., and Hartung H.P. Chemotherapy-induced peripheral neuropathy. J. Neurol. 249 (2002) 9-17
47. Raoul C., Henderson C.E., and Pettmann B. Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J. Cell Biol. 147 (1999) 1049-1062
48. Rebillard A., Tekpli X., Meurette O., Sergent O., LeMoigne-Muller G., Vernhet L., Gorria M., Chevanne M., Christmann M., Kaina B., Counillon L., Gulbins E., Lagadic-Gossmann D., and Dimanche-Boitrel M.T. Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells. Cancer Res. 67 (2007) 7865-7874
49. Reed J.C. Apoptosis mechanisms: implications for cancer drug discovery. Oncology 18 (2004) 11-20
50. Reglodi D., Somogyvari-Vigh A., Vigh S., Kozicz T., and Arimura A. Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. Stroke 31 (2000) 1411-1417
51. Siomek A., Tujakowski J., Gackowski D., Rozalski R., Foksinski M., Dziaman T., Roszkowski K., and Olinski R. Severe oxidatively damaged DNA after cisplatin treatment of cancer patients. Int. J. Cancer 119 (2006) 2228-2230
52. Stoffel W., Jenke B., Block B., Zumbansen M., and Koebke J. Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4554-4559
53. Strait K.A., Warnick C.T., Ford C.D., Dabbas B., Hammond E.H., and Ilstrup S.J. Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2-related protein Bad. Mol. Cancer Ther. 4 (2005) 603-611
54. Suh J., Lu N., Nicot A., Tatsuno I., and DiCicco-Bloom E. PACAP is an anti-mitogenic signal in developing cerebral cortex. Nat. Neurosci. 4 (2001) 123-124
55. Tannock I.F., and Lee C. Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs. Br. J. Cancer 84 (2001) 100-105
56. Tate T.J., Blessing J.A., DeGeest K., Look K.Y., and Homesley H.D. Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study. Gynecol. Oncol. 93 (2004) 336-339
57. Tulub A.A., and Stefanov V.E. Cisplatin stops tubulin assembly into microtubules. A new insight into the mechanism of antitumor activity of platinum complexes. Int. J. Biol. Macromol. 28 (2001) 191-198
58. Vaudry D., Gonzalez B.J., Basille M., Fournier A., and Vaudry H. Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9415-9420
59. Vaudry D., Chen Y., Ravni A., Hamelink C., Elkahloun A.G., and Eiden L.E. Analysis of the PC12 cell transcriptome after differentiation with pituitary adenylate cyclase-activating polypeptide (PACAP). J. Neurochem. 83 (2002) 1272-1284
60. Vaudry D., Rousselle C., Basille M., Falluel-Morel A., Pamantung T.F., Fontaine M., Fournier A., Vaudry H., and Gonzalez B.J. Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 6398-6403
61. Vaudry D., Falluel-Morel A., Basille M., Pamantung T.F., Fontaine M., Fournier A., Vaudry H., and Gonzalez B.J. Pituitary adenylate cyclase-activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells. J. Neurosci. Res. 72 (2003) 303-316
62. Vaudry D., Cottet-Rousselle C., Basille M., Falluel-Morel A., Fournier A., Vaudry H., and Gonzalez B.J. Pituitary adenylate cyclase-activating polypeptide inhibits caspase-3 activity but does not protect cerebellar granule neurons against beta-amyloid (25-35)-induced apoptosis. Regul. Pept. 123 (2004) 43-49
63. Villalba M., Bockaert J., and Journot L. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J. Neurosci. 17 (1997) 83-90
64. Viniegra J.G., Losa J.H., Sánchez-Arévalo V.J., Parada Cobo C., Soria V.M., Ramón y Cajal S., and Sánchez-Prieto R. Modulation of PI3K/Akt pathway by E1a mediates sensitivity to cisplatin. Oncogene 21 (2002) 7131-7136
65. Wang G., Reed E., and Li Q.Q. Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer. Oncol. Rep. 12 (2004) 955-965
66. Wang X., Chen S., Ma G., Ye M., and Lu G. Involvement of proinflammatory factors, apoptosis, caspase-3 activation and Ca2+ disturbance in microglia activation-mediated dopaminergic cell degeneration. Mech. Ageing Dev. 126 (2005) 1241-1254
67. Watanabe J., Ohba M., Ohno F., Kikuyama S., Nakamura M., Nakaya K., Arimura A., Shioda S., and Nakajo S. Pituitary adenylate cyclase-activating polypeptide-induced differentiation of embryonic neural stem cells into astrocytes is mediated via the beta isoform of protein kinase C. J. Neurosci. Res. 84 (2006) 1645-1655
68. Wick A., Wick W., Hirrlinger J., Gerhardt E., Dringen R., Dichgans J., Weller M., and Schulz J.B. Chemotherapy-induced cell death in primary cerebellar granule neurons but not in astrocytes: in vitro paradigm of differential neurotoxicity. J. Neurochem. 91 (2004) 1067-1074
69. Zhang M., Qian J., Xing X., Kong F.M., Zhao L., Chen M., and Lawrence T.S. Inhibition of the tumor necrosis factor-{alpha} pathway is radioprotective for the lung. Clin. Cancer Res. 14 (2008) 1868-1876
70. Zhokhov S.S., Desfeux A., Aubert N., Falluel-Morel A., Fournier A., Laudenbach V., Vaudry H., and Gonzalez B.J. Bax siRNA promotes survival of cultured and allografted granule cell precursors through blockade of caspase-3 cleavage. Cell Death Differ 15 (2008) 1042-1053